Lupin announces launch of diagnostics business in India
Lupin also stated that it has established a 45,000 sq ft National Reference Laboratory in Navi Mumbai.
- Dec 10, 2021,
- Updated Dec 10, 2021 2:38 PM IST
Pharma major Lupin Ltd on Friday announced the launch of its diagnostics arm as part of its strategy to provide integrated healthcare in India.
"As part of its strategy to provide integrated healthcare in India, Lupin Diagnostics, a wholly owned subsidiary of Lupin has formally commenced operations," the homegrown pharma company said in a statement.
Lupin also stated that it has established a 45,000 sq ft National Reference Laboratory in Navi Mumbai. The core facilities of the laboratory include all major diagnostics services, preventive health checkups, and a comprehensive range of tests.
All the processing will be operated by Lupin Healthcare as a hub and will be connected to a nation-wide network of regional, satellite and collection centers. In addition, Lupin is identifying franchisee partners for the initiative, it added.
Commenting on the development, Lupin Managing Director Nilesh Gupta said, ''combining decades of experience and knowledge in the field of therapeutics, we aim to provide our doctors, patients and consumers with the same experience offering quality diagnostic services that are built on trust.''
"The pandemic has elevated healthcare to the top of the global agenda. The role of diagnostics is crucial to improving the health and well-being of society," said Rajeev Sibal, President, India Region Formulations, Lupin.
Lupin Diagnostics will provide a comprehensive range of diagnostic tests. These include molecular diagnostics, cytogenetics, flow cytometry, microbiology, serology, histopathology and cytology, haematology and immunology, among others, the company's statement further added.
The core facilities of the laboratory include major diagnostics services, preventive health checkups, and a comprehensive range of tests. The company also stated that all the processing will be operated by Lupin Healthcare as a hub and will be connected to a nation-wide network of regional, satellite and collection centers.
Lupin shares on BSE were trading 0.40 per cent lower at Rs 884.20 apiece during late trade.
Pharma major Lupin Ltd on Friday announced the launch of its diagnostics arm as part of its strategy to provide integrated healthcare in India.
"As part of its strategy to provide integrated healthcare in India, Lupin Diagnostics, a wholly owned subsidiary of Lupin has formally commenced operations," the homegrown pharma company said in a statement.
Lupin also stated that it has established a 45,000 sq ft National Reference Laboratory in Navi Mumbai. The core facilities of the laboratory include all major diagnostics services, preventive health checkups, and a comprehensive range of tests.
All the processing will be operated by Lupin Healthcare as a hub and will be connected to a nation-wide network of regional, satellite and collection centers. In addition, Lupin is identifying franchisee partners for the initiative, it added.
Commenting on the development, Lupin Managing Director Nilesh Gupta said, ''combining decades of experience and knowledge in the field of therapeutics, we aim to provide our doctors, patients and consumers with the same experience offering quality diagnostic services that are built on trust.''
"The pandemic has elevated healthcare to the top of the global agenda. The role of diagnostics is crucial to improving the health and well-being of society," said Rajeev Sibal, President, India Region Formulations, Lupin.
Lupin Diagnostics will provide a comprehensive range of diagnostic tests. These include molecular diagnostics, cytogenetics, flow cytometry, microbiology, serology, histopathology and cytology, haematology and immunology, among others, the company's statement further added.
The core facilities of the laboratory include major diagnostics services, preventive health checkups, and a comprehensive range of tests. The company also stated that all the processing will be operated by Lupin Healthcare as a hub and will be connected to a nation-wide network of regional, satellite and collection centers.
Lupin shares on BSE were trading 0.40 per cent lower at Rs 884.20 apiece during late trade.